Possible tool to help cocaine users kick the habit
October 7, 2011 in Medical research
A close up of a young woman snorting cocaine during the 1920s. Image by Hulton-Deutsch Collection/CORBIS. Credit: Foxtongue from Flickr
Medicines which increase levels of the brain chemical dopamine may hold the key to helping those addicted to cocaine and amphetamines kick the habit, researchers from the University of Cambridge have found.
Unlike heroin users who may benefit from methadone when attempting to quit, there is currently no medication which has proven to be an effective tool in assisting cocaine and amphetamines users when attempting to quit.
Treatment for stimulant dependence is difficult and often individuals battling addiction relapse several times, said Dr Karen Ersche, of the Behavioural and Clinical Neuroscience Institute (BCNI) at the University of Cambridge, who led the research.
At the moment, the standard treatment for people dependent on cocaine and amphetamines mainly involves behavioural approaches such as counselling and cognitive-behavioural therapy which are useful. However, our research provides important insight into the potential development of medications which could help curb the desire of those plagued with addiction, increasing the likelihood of a successful recovery.
For the research, Dr. Ersche and her Cambridge colleagues asked stimulant-dependent individuals and volunteers who do not use drugs to perform a learning task while their brains were scanned. They found that stimulant-dependent people had problems with adjusting their behavior when one of the rules was changed they persistently responded to the previously correct stimulus despite being repeatedly told that the rule had changed and their responses were wrong.
Dr. Ersche added: Their inflexible performance on the task resembles their drug-taking habits in as much as stimulant-dependent people do almost everything to take drugs even when there are negative consequences such as job loss, debts, or relationship breakups.
The brain scans which were conducted while the patients performed the learning task showed that this persistent behavior was directly linked with reduced activation in the brain reward system. However, when the drug users were given a medication that increased the chemical dopamine in the brain reward centre, their performance improved and their brain activation normalised.
Dr. Ersche concluded: However, before this medication can be used for the treatment of stimulant-dependent individuals in clinical practice, more research would be needed using multiple doses over longer period of time.
Previous research by the same research group had found that parts of the brain reward system where cocaine exerts its actions were significantly enlarged in cocaine users, which the scientists believe renders these individuals more vulnerable to the effects of the drugs.
Provided by
University of Cambridge
-
Abnormal brain structure linked to chronic cocaine abuse
Jun 21, 2011 |
not rated yet |
0
-
Parkinson's drug offers insight into helping cocaine users kick habit
Jun 07, 2010 |
not rated yet |
0
-
Hope for treatment of cocaine addiction
Nov 17, 2010 |
not rated yet |
0
-
Cocaine: Perceived as a reward by the brain?
May 19, 2009 |
not rated yet |
0
-
Research indicates that a common heart drug may reduce cocaine cravings
Feb 27, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Study reveals new mechanism for estrogen suppression of liver lipid synthesis
By discovering the new mechanism by which estrogen suppresses lipid synthesis in the liver, UC Irvine endocrinologists have revealed a potential new approach toward treating certain liver diseases.
Medical research
May 23, 2013 |
5 / 5 (1) |
0
|
MRI-based measurement helps predict vascular disease in the brain
Aortic arch pulse wave velocity, a measure of arterial stiffness, is a strong independent predictor of disease of the vessels that supply blood to the brain, according to a new study published in the June issue the journal ...
Medical research
May 23, 2013 |
not rated yet |
0
Antibiotics: A new understanding of sulfonamide nervous system side effects
Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects can include serious neurological ...
Medical research
May 23, 2013 |
not rated yet |
0
|
Scientists discover molecule triggers sensation of itch
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...
Medical research
May 23, 2013 |
5 / 5 (3) |
0
|
Discarded immune cells induce the relocation of stem cells
Spanish researchers have discovered that the daily clearance of neutrophils from the body stimulates the release of hematopoietic stem cells from the bone marrow into the bloodstream, according to a report published today ...
Medical research
May 23, 2013 |
5 / 5 (2) |
0
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Going live: Immune cell activation in multiple sclerosis
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
Help at hand for people with schizophrenia
How can healthy people who hear voices help schizophrenics? Finding the answer for this is at the centre of research conducted at the University of Bergen.
Alzheimer's disease, the soft target of the euthanasia debate
(Medical Xpress)—The way Alzheimer's disease is portrayed by advocacy groups and the media is having undue influence on the euthanasia debate, according to a Deakin University nursing ethics professor.
Oct 07, 2011
Rank: not rated yet
"Acetylcholine enhancement in the nucleus accumbens
prevents addictive behaviors of cocaine and morphine "
"Lecithin may therefore be the method of choice for
accelerating acetylcholine synthesis"
"Results of treatment with lecithin and glucose: Mass scale trials"
"In this special series of 200 cases treated in the Hospital for Tropical Diseases (Calcutta) by this method, complete cure was effected in 70%, the dose was reduced by 80% in 10%, and by 50% in 15% of the cases. The treatment failed completely in 5%, and there was a relapse to the habit in the remaining 5%."